alanine has been researched along with Osteoporosis in 4 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tenofovir alafenamide (TAF) has recently been approved for chronic hepatitis B (CHB)." | 8.95 | Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. ( Hsu, YC; Nguyen, MH; Wei, MT, 2017) |
| "Tenofovir alafenamide (TAF) has recently been approved for chronic hepatitis B (CHB)." | 4.95 | Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. ( Hsu, YC; Nguyen, MH; Wei, MT, 2017) |
| "Gyrate atrophy (GA) is a rare degenerative, hereditary disease characterized by markedly high serum ornithine levels resulting from the deficiency of ornithine-delta-amino transferase (OAT), a mitochondrial matrix enzyme." | 3.73 | Osteoporosis associated with gyrate atrophy: a case report. ( Ahmet, I; Serdar, KS, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, YC | 1 |
| Wei, MT | 1 |
| Nguyen, MH | 1 |
| Shimomura, A | 1 |
| Matsui, I | 1 |
| Hamano, T | 1 |
| Ishimoto, T | 1 |
| Katou, Y | 1 |
| Takehana, K | 1 |
| Inoue, K | 1 |
| Kusunoki, Y | 1 |
| Mori, D | 1 |
| Nakano, C | 1 |
| Obi, Y | 1 |
| Fujii, N | 1 |
| Takabatake, Y | 1 |
| Nakano, T | 1 |
| Tsubakihara, Y | 1 |
| Isaka, Y | 1 |
| Rakugi, H | 1 |
| Ahmet, I | 1 |
| Serdar, KS | 1 |
| Carpenter, TO | 1 |
| Levy, HL | 1 |
| Holtrop, ME | 1 |
| Shih, VE | 1 |
| Anast, CS | 1 |
1 review available for alanine and Osteoporosis
| Article | Year |
|---|---|
Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics.
Topics: Adenine; Age Factors; Alanine; Antiviral Agents; Bone Density; Clinical Decision-Making; Female; Glo | 2017 |
3 other studies available for alanine and Osteoporosis
| Article | Year |
|---|---|
Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats.
Topics: Adenine; Alanine; Animals; Apoptosis; Arginine; Calcium; Calcium Phosphates; Cells, Cultured; Chemic | 2014 |
Osteoporosis associated with gyrate atrophy: a case report.
Topics: Adult; Alanine; Female; Fluorescein Angiography; Glutamic Acid; Gyrate Atrophy; Humans; Lysine; Orni | 2006 |
Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy.
Topics: Alanine; Amino Acid Metabolism, Inborn Errors; Arginine; Bone Development; Child, Preschool; Citrull | 1985 |